Martin Marietta Materials
MLM
479.01
-10.00
-2.04%
Martin Marietta Materials
US · MLM
#614 by market cap
Listed 1970
479.01
-10.00
-2.04%
Live - 5344 symbols - heartbeat 151s ago
· 2026-10-08 07:00
Pre-market
477.57
-0.30%
After-hours
479.01
0.00%
- Market cap
- 34.02B
- P/E (TTM)i
- 11.76
- P/Bi
- 2.95
- EPSi
- 18.77
- Div yieldi
- 0.69%
- 52W posi
- 4%
Reader sentiment
Are you bullish or bearish on MLM?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Good
- Altman Z-Score is 3.56, above the 3.0 "safe zone" threshold.
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year +8.62% YoY
Margins
- Gross margin
- 30.72%
- Operating margin
- 23.66%
- Net margin
- 18.49%
Key ratios & quality
- Enterprise valuei
- 39.34B
- PEG ratioi
- 1.24
- Altman Z-Scorei
- 3.56
PEG uses trailing P/E against the 3-year net income growth rate (9.46%/yr) since forward earnings estimates aren't available here, so this is not a "forward PEG." Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 4.24B | 4.74B | 4.73B | 5.41B | 6.16B | 5.85B | 5.66B | 6.15B |
| Gross profit | 966.60M | 1.18B | 1.25B | 1.35B | 1.42B | 1.75B | 1.64B | 1.89B |
| Selling & admin expenses | 280.60M | 302.70M | 305.90M | 351.00M | 397.00M | 425.00M | 429.00M | 443.00M |
| Research & development | -- | -- | -- | -- | -- | -- | -- | -- |
| Operating profit | 704.20M | 885.40M | 1.01B | 1.03B | 1.22B | 1.33B | 1.25B | 1.46B |
| Pretax profit | 576.10M | 748.30M | 889.30M | 855.50M | 1.09B | 1.23B | 2.37B | 1.23B |
| Tax | 105.70M | 136.30M | 168.20M | 153.20M | 235.00M | 234.00M | 550.00M | 236.00M |
| Net profit | 470.40M | 612.00M | 721.10M | 702.80M | 867.00M | 1.17B | 2.00B | 1.14B |
| Basic EPS | 7 | 10 | 12 | 11 | 14 | 19 | 33 | 19 |
| Diluted EPS | 7.43 | 9.74 | 11.54 | 11.22 | 13.87 | 18.82 | 32.41 | 18.77 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Revenue | 1.16B | 1.61B | 1.85B | 1.53B | 1.36B | 1.95B |
| Gross profit | 315.00M | 496.00M | 611.00M | 467.00M | 310.00M | 495.00M |
| Selling & admin expenses | 125.00M | 104.00M | 110.00M | 103.00M | 133.00M | 116.00M |
| Research & development | -- | -- | -- | -- | -- | -- |
| Operating profit | 181.00M | 415.00M | 510.00M | 350.00M | 167.00M | 390.00M |
| Pretax profit | 132.00M | 365.00M | 450.00M | 279.00M | 117.00M | 320.00M |
| Tax | 28.00M | 73.00M | 89.00M | 46.00M | 38.00M | 64.00M |
| Net profit | 116.00M | 328.00M | 414.00M | 279.00M | 1.51B | 251.00M |
| Basic EPS | 2 | 5 | 7 | 5 | 25 | 4 |
| Diluted EPS | 1.90 | 5.43 | 6.85 | 4.62 | 25.06 | 4.17 |
Balance sheet
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 1.37B | 1.43B | 1.67B | 2.03B | 2.88B | 3.92B | 2.45B | 3.19B |
| Cash & ST investments | 44.90M | 21.00M | 207.30M | 258.40M | 358.00M | 1.27B | 670.00M | 67.00M |
| Inventory | 663.00M | 690.80M | 709.00M | 752.60M | 873.70M | 989.00M | 1.02B | 1.08B |
| Total assets | 9.55B | 10.13B | 10.58B | 14.39B | 14.99B | 15.13B | 18.17B | 18.71B |
| Total current liabilities | 786.70M | 838.50M | 499.30M | 752.60M | 1.45B | 1.17B | 1.00B | 895.00M |
| Short-term debt | 390.00M | 392.70M | 48.60M | 53.90M | 751.20M | 453.00M | 180.00M | 92.00M |
| Long-term debt | 2.73B | 2.43B | 2.63B | 5.10B | 4.34B | 3.95B | 5.29B | 5.29B |
| Total liabilities | 4,602,000,000.00 | 4,778,300,000.00 | 4,687,500,000.00 | 7,855,400,000.00 | 7,820,800,000.00 | 7,089,000,000.00 | 8,714,000,000.00 | 8,677,000,000.00 |
| Total equity | 4.95B | 5.35B | 5.89B | 6.54B | 7.17B | 8.04B | 9.46B | 10.03B |
| Retained earnings | 1.69B | 2.08B | 2.61B | 3.16B | 3.72B | 4.56B | 5.92B | 6.40B |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Total current assets | 2.10B | 2.39B | 3.42B | 3.19B | 2.36B | 2.45B |
| Cash & ST investments | 101.00M | 225.00M | 57.00M | 67.00M | 273.00M | 112.00M |
| Inventory | 1.17B | 1.16B | 1.03B | 1.08B | 1.21B | 1.17B |
| Total assets | 17.72B | 18.07B | 18.65B | 18.71B | 20.50B | 21.31B |
| Total current liabilities | 935.00M | 1.02B | 1.15B | 895.00M | 1.03B | 1.74B |
| Short-term debt | 184.00M | 187.00M | 291.00M | 92.00M | 65.00M | 930.00M |
| Long-term debt | 5.29B | 5.29B | 5.29B | 5.29B | 5.29B | 5.09B |
| Total liabilities | 8,640,000,000.00 | 8,704,000,000.00 | 8,915,000,000.00 | 8,677,000,000.00 | 9,200,000,000.00 | 9,757,000,000.00 |
| Total equity | 9.08B | 9.37B | 9.74B | 10.03B | 11.30B | 11.55B |
| Retained earnings | 5.53B | 5.81B | 6.17B | 6.40B | 7.66B | 7.86B |
Cash flow
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 705.10M | 966.10M | 1.05B | 1.14B | 991.00M | 1.53B | 1.46B | 1.79B |
| Depreciation & amortization | 344.00M | 371.50M | 393.50M | 451.70M | 506.00M | 513.00M | 573.00M | 637.00M |
| Free cash flow | 329.10M | 572.60M | 690.40M | 714.60M | 509.00M | 878.00M | 604.00M | 978.00M |
| Dividends paid | -116.40M | -129.80M | -140.30M | -147.80M | -160.00M | -174.00M | -189.00M | -197.00M |
| Stock buybacks / issuance | -100.40M | -98.20M | -50.00M | 0 | -150.00M | -150.00M | -450.00M | -450.00M |
| Ending cash balance | 44.90M | 21.00M | 304.40M | 258.90M | 359.00M | 1.28B | 670.00M | 67.00M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Operating cash flow | 218.00M | 387.00M | 551.00M | 629.00M | 227.00M | 112.00M |
| Depreciation & amortization | 154.00M | 167.00M | 159.00M | 157.00M | 167.00M | 204.00M |
| Free cash flow | -15.00M | 208.00M | 361.00M | 424.00M | 41.00M | -16.00M |
| Dividends paid | -49.00M | -48.00M | -50.00M | -50.00M | -51.00M | -51.00M |
| Stock buybacks / issuance | -450.00M | 0 | 0 | 0 | -200.00M | 0 |
| Ending cash balance | 101.00M | 236.00M | 70.00M | 67.00M | 273.00M | 120.00M |
Returns & efficiency
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | 9.75 | 11.87 | 12.82 | 11.30 | 12.50 | 15.78 | 22.82 | 11.67 |
| ROA %i | 5.06 | 6.21 | 6.96 | 5.62 | 5.83 | 7.97 | 11.98 | 6.17 |
| ROIC %i | 7.37 | 8.60 | 9.28 | 7.78 | 8.02 | 10.51 | 15.17 | 8.54 |
| 5-year avg ROE %i | 9.66 | 10.98 | 12.18 | 12.37 | 11.68 | 12.80 | 14.99 | 14.76 |
| EBIT margin %i | 16.80 | 18.52 | 21.30 | 18.44 | 20.45 | 24.47 | 42.30 | 23.67 |
| FCF / sales %i | 7.76 | 12.08 | 14.60 | 13.20 | 8.27 | 12.96 | 9.24 | 15.90 |
| Current ratioi | 1.74 | 1.70 | 3.34 | 2.69 | 1.99 | 3.35 | 2.44 | 3.57 |
| Quick ratioi | 0.72 | 0.71 | 1.57 | 1.37 | 0.79 | 1.73 | 1.35 | 0.88 |
| Debt / assetsi | 32.67 | 32.18 | 29.15 | 38.45 | 36.20 | 31.25 | 31.89 | 30.49 |
| LT debt / equityi | 55.20 | 53.59 | 51.54 | 83.86 | 65.22 | 53.19 | 59.40 | 55.95 |
| Interest coveragei | 5.20 | 6.79 | 8.53 | 7.00 | 7.46 | 10.03 | 16.36 | 6.33 |
| Revenue CAGR (3Y) %i | 6.24 | 7.46 | 6.05 | 8.45 | 9.14 | 7.35 | 1.50 | -0.06 |
| Net income CAGR (3Y) %i | 17.63 | 12.88 | 0.36 | 14.34 | 12.32 | 17.48 | 41.61 | 9.46 |
| FCF CAGR (3Y) %i | 7.85 | 23.81 | 40.81 | 29.49 | -3.85 | 8.34 | -5.45 | 24.32 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| ROE %i | 11.87 | 12.09 | 12.19 | 11.67 | 24.87 | 23.50 |
| ROA %i | 6.28 | 6.39 | 6.56 | 6.17 | 13.26 | 12.48 |
| ROIC %i | 8.52 | 8.79 | 9.11 | 8.54 | 17.05 | 15.98 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 22.82 | 23.52 | 24.53 | 23.67 | 22.69 | 20.90 |
| FCF / sales %i | 9.30 | 14.41 | 14.59 | 15.90 | 16.28 | 12.11 |
| Current ratioi | 2.25 | 2.35 | 2.97 | 3.57 | 2.28 | 1.41 |
| Quick ratioi | 0.89 | 1.11 | 0.90 | 0.88 | 1.02 | 0.65 |
| Debt / assetsi | 32.76 | 32.15 | 31.65 | 30.49 | 27.75 | 29.78 |
| LT debt / equityi | 61.92 | 60.04 | 57.65 | 55.95 | 49.78 | 46.90 |
| Interest coveragei | 8.19 | 7.74 | 7.59 | 6.33 | 6.27 | 6.03 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
✦ Quant Revenue Concentration how this is computed
Single-engine
- Aggregates is the largest reported line at 78.74% of revenue, across 4 reported segments.
- The next-largest line, Other Building Materials, is a distant second at 15.56% - a sharp slowdown here would have little to offset it.
Revenue breakdown most recent period
Business
Aggregates78.74%
Other Building Materials15.56%
Specialties7.81%
Quote time 2026-10-08 07:00:14 · For reference only, not investment advice and not tailored to your situation.